Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model

References

• Alizadeh BZ, Hanifi-Moghaddam P, Eerligh P, van der Slik AR, Kolb H, Kharagjitsingh AV, Pereira Arias AM, Ronkainen M, Knip M, Bonfanti R. 2006. Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes. Clin Exp Immunol. 145(3):480–484.
   PubMed Web of Science ®Google Scholar
• Al-Salami H, Mamo JC, Mooranian A, Negrulj R, Lam V, Elahy M, Takechi R. 2017. Long-term supplementation of microencapsulated ursodeoxycholic acid prevents hypertension in a mouse model of insulin resistance. Exp Clin Endocrinol Diabetes. 125(1):28–32.
   PubMed Web of Science ®Google Scholar
• Castro-Rosas J, Ferreira-Grosso CR, Gomez-Aldapa CA, Rangel-Vargas E, Rodriguez-Marin ML, Guzman-Ortiz FA, Falfan-Cortes RN. 2017. Recent advances in microencapsulation of natural sources of antimicrobial compounds used in food – A review. Food Res Int. 102:575–587.
   PubMed Web of Science ®Google Scholar
• Chang TM. 2005. Therapeutic applications of polymeric artificial cells [10.1038/nrd1659]. Nat Rev Drug Discov. 4(3):221–235.
   PubMed Web of Science ®Google Scholar
• Dias MI, Ferreira IC, Barreiro MF. 2015. Microencapsulation of bioactives for food applications. Food Funct. 6(4):1035–1052.
   PubMed Web of Science ®Google Scholar
• Engin F, Yermalovich A, Nguyen T, Hummasti S, Fu W, Eizirik DL, Mathis D, Hotamisligil GS. 2013. Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes. Sci Trans Med. 5(211):211ra156.
   PubMed Web of Science ®Google Scholar
• Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, Watada H, Kuroda A, Kawamori D, Yasuda T, Matsuhisa M, Yamasaki Y, et al. 2002. Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract. 57(1):1–10.
   PubMed Web of Science ®Google Scholar
• Hong SC, Zhao SP, Wu ZH. 2007. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits. Int J Cardiol. 115(1):29–35.
   PubMed Web of Science ®Google Scholar
• Jiang M, Wang T, Xu Q, Wu Y. 2009. Novel amphiphilic hyperbranched poly (amine-ester) copolymers nanoparticles as protein drug delivery. Mini Rev Med Chem. 9(11):1342–1356.
   PubMed Web of Science ®Google Scholar
• Lee SH, Zhang Z, Feng SS. 2007. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. Biomaterials. 28(11):2041–2050.
   PubMed Web of Science ®Google Scholar
• Mamo JC, Lam V, Al-Salami H, Brook E, Mooranian A, Nesbit M, Graneri L, D'Alonzo Z, Fimognari N, Stephenson A, et al. 2018. Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration. Ther Deliv. 9(10):703–709.
   PubMed Web of Science ®Google Scholar
• Mamo JC, Lam V, Brook E, Mooranian A, Al-Salami H, Fimognari N, Nesbit M, Takechi R. 2019. Probucol prevents blood-brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet. Diabetes Vascular Dis Res. 16(1):87–97.
   PubMed Web of Science ®Google Scholar
• Mamo JCL, Lam V, Giles C, Coulson SH, Fimognari N, Mooranian A, Al-Salami H, Takechi R. 2017. Antihypertensive agents do not prevent blood-brain barrier dysfunction and cognitive deficits in dietary-induced obese mice. Int J Obesity. 41(6):926–934.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, Mukkur T, Mikov M, Lalic-Popovic M, Stojancevic M, et al. 2014a. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J Pharm Innov. 9(2):150–157.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Takechi R, Jamieson E, Morahan G, Al-Salami H. 2017a. New biotechnological microencapsulating methodology utilizing individualized gradient-screened jet laminar flow techniques for pancreatic beta-cell delivery: bile acids support cell energy-generating mechanisms. Mol Pharm. 14(8):2711–2718.
   PubMedGoogle Scholar
• Mooranian A, Negrulj R, Al-Salami H. 2016a. Primary bile acid chenodeoxycholic acid-based microcapsules to examine β-cell survival and the inflammatory response. BioNanoSci. 6(2):103–109.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. 2016b. The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable β-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies. Drug Deliv Transl Res. 6(1):17–23.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. 2017b. The effects of ionic gelation- vibrational jet flow technique in fabrication of microcapsules incorporating β-cell: applications in diabetes. Curr Diabetes Rev. 13(1):91–96.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Sallami HS, Fang Z, Mikov M, Golocorbin-Kon S, Fakhoury M, Arfuso F, Al-Salami H. 2015a. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment. J Microencapsul. 32(2):151–156.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Sallami HS, Fang Z, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, Matthews V, Arfuso F, et al. 2015b. Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes. AAPS PharmSciTech. 16(1):45–52.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, Al-Salami H. 2016c. Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic beta-cells. Artif Cells Nanomed Biotechnol. 44(1):194–200.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, Al-Salami H. 2016d. Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic beta-cell line. Artif Cells Nanomed Biotechnol. 44(7):1642–1653.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Al-Sallami HS, Fang Z, Mukkur T, Mikov M, Golocorbin-Kon S, Fakhoury M, Arfuso F, et al. 2014b. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Des Devel Ther. 8:1003–1012.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Al-Sallami HS, Fang Z, Mukkur TK, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, et al. 2014c. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol. Drug Des Devel Ther. 8:1221–1230.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Fakhoury M, Arfuso F, Jones F, Al-Salami H. 2016e. Advanced bile acid-based multi-compartmental microencapsulated pancreatic beta-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment. Artif Cells Nanomed Biotechnol. 44(2):588–595.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Fakhoury M, Jones F, Arfuso F, Al-Salami H. 2015c. Novel multicompartmental bile acid-based microcapsules for pancreatic beta-cell transplantation. Xenotransplantation. 22:93–94.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Watts GF, Arfuso F, Al-Salami H. 2014d. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Des Devel Ther. 8:1673–1683.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Jamieson E, Morahan G, Al-Salami H. 2016f. Biological assessments of encapsulated pancreatic beta-cells: their potential transplantation in diabetes. Cel Mol Bioeng. 9(4):530–537.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, Mukkur TK, Mikov M, Lalic-Popovic M, Stojancevic M, et al. 2015d. An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm Develop Technol. 20(6):702–709.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Takechi R, Jamieson E, Morahan G, Al-Salami H. 2017c. Alginate-combined cholic acid increased insulin secretion of microencapsulated mouse cloned pancreatic beta cells. Ther Deliv. 8(10):833–842.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Takechi R, Jamieson E, Morahan G, Al-Salami H. 2017d. Influence of biotechnological processes, speed of formulation flow and cellular concurrent stream-integration on insulin production from β-cells as a result of co-encapsulation with a highly lipophilic bile acid. Cel Mol Bioeng. 11:65–75
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Takechi R, Jamieson E, Morahan G, Al-Salami H. 2018a. Electrokinetic potential-stabilization by bile acid-microencapsulating formulation of pancreatic β-cells cultured in high ratio poly-L-ornithine-gel hydrogel colloidal dispersion: applications in cell-biomaterials, tissue engineering and biotechnological applications. Artif Cells Nanomed Biotechnol. 46(6):1156–1162.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Takechi R, Mamo J, Al-Sallami H, Al-Salami H. 2018b. The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects. Drug Deliv Transl Res. 8(3):543–551.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Tackechi R, Jamieson E, Morahan G, Al-Salami H. 2017e. Innovative microcapsules for pancreatic beta-cells harvested from mature double-transgenic mice: cell imaging, viability, induced glucose-stimulated insulin measurements and proinflammatory cytokines analysis. Pharm Res. 34(6):1217–1223.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Takechi R, Jamieson E, Morahan G, Al-Salami H. 2018c. The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic beta-cells: biomaterials, osmotic forces and potential applications in diabetes treatment. Pharm Develop Technol. 23(2):145–150.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Zamani N, Mikov M, Golocorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H. 2018d. Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses. Artif Cells Nanomed Biotechnol. 46(sup3):S741–S747.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H. 2018e. Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid. Ther Deliv. 9(11):811–821.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Zamani N, Takechi R, Al-Sallami H, Mikov M, Goločorbin-Kon S, Kovacevic B, Arfuso F, Al-Salami H. 2018f. Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes. Artif Cells Nanomed Biotechnol. 46(sup3):S748–S754.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H. 2019. Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatment. Ther Deliv. 10(2):99–106.
   Google Scholar
• Negrulj RM, Al-Salami H. 2013. Potentials and limitations of bile acids in type 2 diabetes mellitus: applications of microencapsulation as a novel oral delivery system. J Endocrinol Diabetes Mellitus. 1(2):49–59.
   Google Scholar
• Negrulj R, Mooranian A, Chen-Tan N, Al-Sallami HS, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, Arfuso F, Al-Salami H. 2016. Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes. Artif Cells Nanomed Biotechnol. 44(5):1290–1297.
   PubMed Web of Science ®Google Scholar
• Ou J, Saku K, Jimi S, Liao YL, Ohta T, Zhang B, Arakawa K. 1999. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits. Jpn Circ J. 63(6):471–477.
   PubMedGoogle Scholar
• Sha X, Wu J, Chen Y, Fang X. 2012. Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation [Research Support, Non-U.S. Gov't]. Int J Nanomed. 7:705–712.
   PubMed Web of Science ®Google Scholar
• Takechi R, Lam V, Brook E, Giles C, Fimognari N, Mooranian A, Al-Salami H, Coulson SH, Nesbit M, Mamo J. 2017. Blood-brain barrier dysfunction precedes cognitive decline and neurodegeneration in diabetic insulin resistant mouse model: an implication for causal link. Front Aging Neurosci. 9:399.
   PubMed Web of Science ®Google Scholar
• Tchorzewski H, Głowacka E, Banasik M, Lewkowicz P, Szałapska-Zawodniak M. 2001. Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-gamma, interleukin-6 and interleukin-10 and undergo anti-CD95 induced apoptosis after insulin stimulation. Immunol Lett. 75(3):225–234.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Jiang S, Liu Z, Niu B, Gu W, Li Y, Cui J. 2014. Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation. Pharm Res. 31(9):2266–2275.
   PubMed Web of Science ®Google Scholar